Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 4, 2005, Pages 745-750

  Subbarao, Padmaja ^a,b   Dorman, Sandra C ^a   Rerecich, Tracey ^a   Watson, Richard M ^a   Gauvreau, Gail M ^a   O'Byrne, Paul M ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Allergen challenge; Asthma; Bronchial challenge test; Budesonide; Eosinophils; Fluticasone; Sputum; Steroids

Indexed keywords

ALLERGEN; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; PLACEBO;

ADULT; AIRWAY; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HUMAN; MALE; OBSERVATION; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SPUTUM;

EID: 16244398341     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.11.023     Document Type: Article

References (35)

1. L.P. Boulet, A. Becker, D. Berube, R. Beveridge, and P. Ernst Canadian asthma consensus report, 1999. Canadian Asthma Consensus Group CMAJ 161 suppl 11 1999 S1 S61
2. P.M. O'Byrne, J. Dolovich, and F.E. Hargreave Late asthmatic responses Am Rev Respir Dis 136 1987 740 751
3. G.M. Gauvreau, J. Doctor, R.M. Watson, M. Jordana, and P.M. O'Byrne Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation Am J Respir Crit Care Med 154 1996 1267 1271
4. D.W. Cockcroft, D.N. Killian, J.J. Mellon, and F.E. Hargreave Bronchial reactivity to inhaled histamine: a method and clinical survey Clin Allergy 7 1977 235 243
5. M.D. Inman, R.M. Watson, T. Rerecich, G.M. Gauvreau, B.N. Lutsky, and P. Stryszak Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge Am J Respir Crit Care Med 164 2001 569 574
6. E.A.B. Kelly, W.W. Busse, and N.N. Jarjour Inhaled budesonide decreases airway inflammatory response to allergen Am J Respir Crit Care Med 162 2000 883 890
7. L.J. Wood, R. Sehmi, G.M. Gauvreau, R.M. Watson, R. Foley, and J.A. Denburg An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects Am J Respir Crit Care Med 159 1999 1457 1463
8. K. Parameswaran, M.D. Inman, R.M. Watson, M.M. Morris, A. Efthimiadis, and P.G. Ventresca Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers Can Respir J 7 2000 313 319
9. L. Thorsson, S. Edsbacker, A. Kallen, and C.G. Lofdahl Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler Br J Clin Pharmacol 52 2001 529 538
10. M. Johnson Development of fluticasone propionate and comparison with other inhaled corticosteroids J Allergy Clin Immunol 101 suppl 1998 S434 S439
11. A. Miller-Larsson, H. Mattsson, E. Hjertberg, M. Dahlback, A. Tunek, and R. Brattsand Reversible fatty acid conjugation of budesonide - novel mechanism for prolonged retention of topically applied steroid in airway tissue Drug Metab Dispos 26 1998 623 630
12. M.D. Inman, R. Watson, D.W. Cockcroft, B.J. Wong, F.E. Hargreave, and P.M. O'Byrne Reproducibility of allergen-induced early and late asthmatic responses J Allergy Clin Immunol 95 1995 1191 1195
13. D.W. Cockcroft, K.Y. Murdock, J. Kirby, and F. Hargreave Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine Am Rev Respir Dis 135 1987 264 267
14. M.M.M. Pizzichini, E. Pizzichini, L. Clelland, A. Efthimiadis, J. Mahony, and J. Dolovich Sputum in severe exacerbations of asthma - kinetics of inflammatory indices after prednisone treatment Am J Respir Crit Care Med 155 1997 1501 1508
15. J.K. Peat, W.R. Unger, and D. Combe Measuring changes in logarithmic data, with special reference to bronchial responsiveness J Clin Epidemiol 47 1994 1099 1108
16. P.G. Gibson, N. Saltos, and K. Fakes Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial Am J Respir Crit Care Med 163 2001 32 36
17. B.J. Thio, G.L. Slingerland, A.F. Nagelkerke, J.J. Roord, P.G. Mulder, and J.E. Dankert-Roelse Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study Pediatr Pulmonol 32 2001 115 121
18. A.M. Bentley, S. Walker, F. Hanotte, C. De Vos, and S.R. Durham A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness Clin Exp Allergy 26 1996 909 917
19. D.W. Cockcroft, and K.Y. Murdock Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine J Allergy Clin Immunol 79 1987 734 740
20. D.W. Cockcroft, C.P. McParland, P.M. O'Byrne, P. Manning, J.L. Friend, and B.C. Rutherford Beclomethasone given after the early asthmatic response inhibits the late response and the increased methacholine responsiveness and cromolyn does not J Allergy Clin Immunol 91 1993 1163 1168
21. J.C. Kidney, L.P. Boulet, F.E. Hargreave, F. Deschesnes, V.A. Swystun, and P.M. Obyrne Evaluation of single dose inhaled corticosteroid activity with an allergen challenge model J Allergy Clin Immunol 100 1997 65 70
22. B.B. Larsen, L.P. Nielsen, R. Engelstatter, V. Steinijans, and R. Dahl Effect of ciclesonide on allergen challenge in subjects with bronchial asthma Allergy 58 2003 207 212
23. V.A. Swystun, R. Bhagat, S. Kalra, B. Jennings, and D.W. Cockcroft Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen J Allergy Clin Immunol 102 1998 363 367
24. R. Leigh, D. Vethanayagam, M. Yoshida, R.M. Watson, T. Rerecich, and M.D. Inman Effects of montelukast and budesonide on airway responses and airway inflammation in asthma Am J Respir Crit Care Med 166 2002 1212 1217
25. K. Asai, H. Kanazawa, H. Kamoi, S. Shiraishi, K. Hirata, and J. Yoshikawa Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Clin Exp Allergy 33 2003 595 599
26. M.D. Inman, K. Parameswaran, R.M. Watson, M.M. Morris, A. Efthimiadis, and R. Lam Effects of fluticasone on allergen-induced airway responses: single dose versus two weeks treatment [abstract] Am J Respir Crit Care Med 159 1999 A633
27. J.H. Toogood, J.C. Baskerville, B. Jennings, N.M. Lefcoe, and S.A. Johansson Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide J Allergy Clin Immunol 70 1982 288 298
28. P. Kuna, H. Magnussen, J. Joubert, and P.M. Greefhorst Same minimal effective dose Of budesonide Turbuhaler® and fluticasone Diskus®/Accuhaler® in adult asthmatics [abstract] Am J Respir Crit Care Med 163 2001 A517
29. S. Edsbacker Pharmacological factors that influence the choice of inhaled corticosteroids Drugs 58 suppl 4 1999 7 16
30. A. Miller-Larsson, P. Jansson, A. Runstrom, and R. Brattsand Prolonged airway activity and improved selectivity of budesonide possibly due to esterification Am J Respir Crit Care Med 162 2000 1455 1461
31. H. Petersen, A. Kullberg, S. Edsbacker, and L. Greiff Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo Br J Clin Pharmacol 51 2001 159 163
32. J.P. Kemp, R.B. Berkowitz, S.D. Miller, J.J. Murray, K. Nolop, and J.E. Harrison Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma J Allergy Clin Immunol 106 2000 485 492
33. M. Noonan, J.P. Karpel, G.W. Bensch, J.W. Ramsdell, D.R. Webb, and K.B. Nolop Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler Ann Allergy Asthma Immunol 86 2001 36 43
34. J. Wolfe, A. Rooklin, J. Grady, Z.M. Munk, A. Stevens, and B. Prillaman Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids J Allergy Clin Immunol 105 2000 1153 1161
35. R. ZuWallack, J. Adelglass, D.P. Clifford, S.P. Duke, P.D. Wire, and M. Faris Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma Chest 118 2000 303 312